NASDAQ:ESPR - Esperion Therapeutics Insider Trading Activity

Sign in or create an account to add this stock to your watchlist.
$41.39 -2.84 (-6.42 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$41.39
Today's Range$41.36 - $44.39
52-Week Range$33.06 - $79.30
Volume514,203 shs
Average Volume620,574 shs
Market Capitalization$1.11 billion
P/E Ratio-5.49
Dividend YieldN/A
Beta2.17

Insider Trades

Esperion Therapeutics (NASDAQ:ESPR) Insider Buying and Selling Activity

Insider Ownership Percentage: 14.50%
Insider Trading History for Esperion Therapeutics (NASDAQ:ESPR)

Esperion Therapeutics (NASDAQ ESPR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2019Timothy M MaylebenCEOBuy5,000$43.48$217,400.0056,163View SEC Filing  
3/19/2019Nicole VitulloDirectorSell15,329$44.73$685,666.178,319View SEC Filing  
3/14/2019Target N V BiotechMajor ShareholderBuy50,000$49.89$2,494,500.003,522,964View SEC Filing  
3/14/2019Timothy M MaylebenCEOBuy5,000$48.73$243,650.0051,163View SEC Filing  
3/12/2019Roger S NewtonDirectorSell25,000$50.06$1,251,500.00548,726View SEC Filing  
1/4/2019Target N V BiotechMajor ShareholderBuy80,000$41.29$3,303,200.003,472,964View SEC Filing  
12/24/2018Target N V BiotechMajor ShareholderBuy50,000$39.91$1,995,500.003,392,964View SEC Filing  
12/17/2018Target N V BiotechMajor ShareholderBuy60,000$47.73$2,863,800.003,342,964View SEC Filing  
11/5/2018Boxer Capital, LlcMajor ShareholderSell100,000$56.38$5,638,000.00View SEC Filing  
11/2/2018Boxer Capital, LlcMajor ShareholderSell40,000$55.21$2,208,400.00View SEC Filing  
11/2/2018Roger S NewtonDirectorSell2,827$50.07$141,547.89573,953View SEC Filing  
10/18/2018Roger S NewtonDirectorSell100$50.00$5,000.00589,326View SEC Filing  
10/16/2018Roger S NewtonDirectorSell9,400$50.01$470,094.00589,326View SEC Filing  
8/27/2018Roger S NewtonDirectorSell17,700$51.05$903,585.00615,726View SEC Filing  
8/17/2018Roger S NewtonDirectorSell7,300$50.06$365,438.00616,426View SEC Filing  
8/3/2018Target N V BiotechMajor ShareholderBuy50,000$46.14$2,307,000.003,282,964View SEC Filing  
7/12/2018Target N V BiotechMajor ShareholderBuy50,000$41.77$2,088,500.003,232,964View SEC Filing  
6/29/2018Target N V BiotechMajor ShareholderBuy50,000$39.48$1,974,000.003,182,964View SEC Filing  
6/21/2018Target N V BiotechMajor ShareholderBuy60,000$38.57$2,314,200.003,132,964View SEC Filing  
6/7/2018Target N V BiotechMajor ShareholderBuy60,000$37.79$2,267,400.003,072,964View SEC Filing  
6/5/2018Target N V BiotechMajor ShareholderBuy60,000$38.47$2,308,200.003,012,964View SEC Filing  
5/21/2018Target N V BiotechMajor ShareholderBuy130,000$40.11$5,214,300.002,872,964View SEC Filing  
5/18/2018Target N V BiotechMajor ShareholderBuy50,000$42.24$2,112,000.002,872,964View SEC Filing  
3/29/2018Roger S NewtonDirectorSell25,000$72.37$1,809,250.00639,682View SEC Filing  
1/25/2018Nicole VitulloDirectorSell11,674$71.79$838,076.463,177View SEC Filing  
12/6/2017Nicole VitulloDirectorSell9,326$53.85$502,205.102,472View SEC Filing  
3/22/2017Dov A Md GoldsteinDirectorSell800,000$41.66$33,328,000.00View SEC Filing  
3/21/2017Gilbert S OmennDirectorBuy1,000$42.26$42,260.0010,000View SEC Filing  
11/1/2016Narendra D LalwaniCOOBuy5,000$9.93$49,650.005,000View SEC Filing  
7/6/2016Mark E McgovernDirectorBuy5,000$10.00$50,000.00600View SEC Filing  
5/4/2016Timothy M MaylebenCEOBuy7,000$14.85$103,950.0041,614View SEC Filing  
3/1/2016Gilbert S OmennDirectorBuy5,000$15.28$76,400.0010,000View SEC Filing  
1/27/2016Timothy M MaylebenCEOBuy3,600$15.88$57,168.0034,614View SEC Filing  
1/15/2016Timothy M MaylebenCEOBuy7,200$14.08$101,376.0031,014View SEC Filing  
4/24/2015Dov A Md GoldsteinDirectorSell217,469$108.22$23,534,495.18View SEC Filing  
11/18/2014Patrick G EnrightDirectorSell487,130$32.78$15,968,121.40View SEC Filing  
10/21/2014Parters Vii L P DomainMajor ShareholderBuy500,000$20.00$10,000,000.00View SEC Filing  
10/7/2014Longitude Capital Partners, LlMajor ShareholderSell11,927$30.04$358,287.08View SEC Filing  
7/1/2013Brian H DoveyMajor ShareholderBuy285,714$14.00$3,999,996.00View SEC Filing  
7/1/2013Daniel JanneyDirectorBuy235,714$14.00$3,299,996.00View SEC Filing  
7/1/2013Roger S NewtonChairmanBuy42,346$14.00$592,844.00View SEC Filing  
7/1/2013Timothy M MaylebenCEOBuy5,000$14.00$70,000.00View SEC Filing  
(Data available from 1/1/2013 forward)
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel